TSXV:BTI.H - Post by User
Post by
craighenryon Dec 27, 2022 5:44pm
217 Views
Post# 35192853
This shows how the Financing Market is out there
This shows how the Financing Market is out thereFor many Biotech alike. Bioasis is no different.
"Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics"
This for Jounce shareholders is almost criminal.
Yes, before the resident but job mouths off, I know this has nothing to do with Bioasis.
My point is that DR probably had no other option other than to file C11.
There is not this big "conspiracy" that the nut job wants you to believe.
Link to the Gilead deal below:
https://www.stockwatch.com/News/Item/U-b20221227005077-U!JNCE-20221227/U/JNCE